Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Smartphone App Outperforms Traditional Coronary Angiography

By HospiMedica International staff writers
Posted on 16 Apr 2018
A smartphone application that assesses ulnar artery patency via photoplethysmography is diagnostically superior to traditional physical examination, according to a new study.

Researchers at the University of Ottawa (Canada), Mount Sinai Health System (MSHS; New York, NY, USA), and other institutions conducted a study in 438 patients in order to compare the use of the Azumio Instant Heart Rate monitoring application on an iPhone 4S to the modified Allen test, which measures blood flow in the radial and ulnar arteries of the wrist in order to evaluate the collateral circulation to the hand, and determine patient eligibility for radial artery access.

Study participants were split into two groups; one group was assessed using the app, and the other was assessed using the Allen test. More...
All patients then underwent conventional plethysmography of the index finger, followed by Doppler ultrasonography of the radial and ulnar arteries. The primary outcome was diagnostic accuracy of the heart rate monitoring application. The results revealed that the Azumio app had a superior diagnostic accuracy (91.8%) than that of the modified Allen test (81.7%). The study was published on April 3, 2018, in the Canadian Medical Association Journal (CMAJ).

“Because of the widespread availability of smartphones, they are being used increasingly as point-of-care diagnostics in clinical settings with minimal or no cost,” said Benjamin Hibbert, MD, of the University of Ottawa Heart Institute. “For example, built-in cameras with dedicated software or photodiode sensors using infrared light-emitting diodes have the potential to render smartphones into functional plethysmographs.”

“When smartphones and apps begin to be used clinically, it is important that they are evaluated in the same rigorous manner by which we assess all therapies and diagnostic tests,” said lead author Pietro Di Santo, MD, of the University of Ottawa. “When we designed the study, we wanted to hold the technology to the highest scientific standards to make sure the data supporting its use was as robust as possible.”

Color Doppler ultrasonography imaging is the gold standard method for assessing arterial patency and collateral competency, but it is relatively resource-intensive and thus seldom feasible or cost-effective in routine clinical practice.

Related Links:
University of Ottawa
Mount Sinai Health System


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.